Iodixanol
Records for this ingredient, by country (identity only).
ATC V08AB09 · 11 markets · 107 records
Iodixanol
Forms
CN 45 records · 8 shown of 8
- 160 g/500 mLinjectionManufacturer: 通用电气药业(上海)有限公司 ×14
- 32,000 mg/100 mLinjection威视派克碘克沙醇Manufacturer: 上海司太立制药有限公司、Manufacturer: 北京北陆药业股份有限公司、Manufacturer: 南京正大天晴制药有限公司、Manufacturer: 广州康臣药业有限公司、Manufacturer: 成都倍特药业股份有限公司、Manufacturer: 扬子江药业集团有限公司、Manufacturer: 正大天晴药业集团股份有限公司、Manufacturer: 通用电气药业(上海)有限公司
- 16,000 mg/50 mLinjection威视派克碘克沙醇Manufacturer: 北京北陆药业股份有限公司、Manufacturer: 成都倍特药业股份有限公司、Manufacturer: 扬子江药业集团有限公司、Manufacturer: 正大天晴药业集团股份有限公司、Manufacturer: 江苏恒瑞医药股份有限公司、Manufacturer: 通用电气药业(上海)有限公司
- 27,000 mg/100 mLinjection威视派克碘克沙醇Manufacturer: 北京北陆药业股份有限公司、Manufacturer: 扬子江药业集团有限公司、Manufacturer: 江苏恒瑞医药股份有限公司、Manufacturer: 通用电气药业(上海)有限公司
- 13,500 mg/50 mLinjection威视派克碘克沙醇Manufacturer: 扬子江药业集团有限公司、Manufacturer: 通用电气药业(上海)有限公司
- 65,200 mg/100 mLinjectionManufacturer: 江苏恒瑞医药股份有限公司 ×5
- 64,000 mg/200 mLinjectionManufacturer: 通用电气药业(上海)有限公司 ×14
- 54,000 mg/200 mLinjectionManufacturer: 通用电气药业(上海)有限公司 ×14
AU 25 records · 2 shown of 2
- 652 mg/mL per mL / per unit basis not statedinjectionVISIPAQUE iodixanol 11.0g/20mL (550mg/mL) injection vialVISIPAQUE iodixanol 13.0g/20mL (652mg/mL) injection ampoule、VISIPAQUE iodixanol 65.2g/100mL (652mg/mL) injection bag、VISIPAQUE iodixanol 65.2g/100mL (652mg/mL) injection bottle
- 550 mg/mL per mL / per unit basis not statedinjectionVISIPAQUE iodixanol 11.0g/20mL (550mg/mL) injection vialVISIPAQUE iodixanol 13.0g/20mL (652mg/mL) injection ampoule、VISIPAQUE iodixanol 65.2g/100mL (652mg/mL) injection bag、VISIPAQUE iodixanol 65.2g/100mL (652mg/mL) injection bottle
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Visipaque ×2
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
GB 12 records · 2 shown of 2
- 652 mg per mL / per unit basis not statedinjectionVisipaque 320 solution for injection 100ml bottles
- 550 mg per mL / per unit basis not statedinjectionVisipaque 270 solution for injection 100ml bottles
JP 5 records · 5 shown of 5
- 65.15 %/50 mLinjectionビジパーク320注100mL
- 65.15 %/100 mLinjectionビジパーク320注100mL
- 54.97 %/20 mLinjectionビジパーク270注100mL
- 54.97 %/50 mLinjectionビジパーク270注100mL
- 54.97 %/100 mLinjectionビジパーク270注100mL
US 4 records · 2 shown of 2
CA 4 records · 2 shown of 2
SG 4 records · 2 shown of 2
- 320 mg/mL per mL / per unit basis not statedinjectionHENGRUI IODIXANOL SOLUTION FOR INJECTION 270 MG I/MLVISIPAQUE INJECTION 320 mgI/ml
- 270 mg/mL per mL / per unit basis not statedinjectionHENGRUI IODIXANOL SOLUTION FOR INJECTION 270 MG I/MLVISIPAQUE INJECTION 270 mgI/ml
TW 2 records · 0 shown of 0
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名VISIPAQUE INJECTION 270MGI/ML ×1VISIPAQUE INJECTIONS 320MGI/ML ×1易渠派克 注射劑 270公絲碘/公撮 ×1易渠派克 注射劑 320 毫克碘/毫升 ×1
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
HK 2 records · 0 shown of 0
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名VISIPAQUE INJ 270MG I/ML ×4
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 2 records · 2 shown of 2
- 65200 mg/100 mLinjectionVISIPAQUE 270 mg d'I/mL, solution injectable
- 55000 mg/100 mLinjectionVISIPAQUE 270 mg d'I/mL, solution injectable
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.